Rhinostat – Information For Physicians

The cornerstone of treating RM is always the same; patients must discontinue their use of the decongestant sprays. Very few patients are capable of tolerating the restricted nasal airflow associated with conventional protocols, which is why the treatment of RM patients often fails. 

Unlike other treatment options, Rhinostat preserves normal airflow as patients are precisely and gradually weaned from the active ingredient in the decongestant.  The patented Rhinostat apparatus and diluent solution allows the patient to taper the dosage strength at a targeted rate of 15% per day. The weaning process typically takes from 17 to 41 days.

Rhinostat Kits are also free from the preservative benzylkonium chloride, which has been shown to exacerbate RM.

The difference can be measured with Rhinomanometry:

Airflow Comparison Chart: Rhinostat vs. Placebo vs. Corticosteriods
Airflow Comparison Chart: Patients using corticosteroids and placebo experience severely restricted airflow for the first 6-7 days, once the decongestants are withdrawn. Patients who are gradually weaned using Rhinostat maintain comfortable airflow during the entire withdrawal period. All patients have similar airflow after 10-14 days

Rhinostat may be used in conjunction with intranasal or systemic steroids or as a standalone therapy.  Each Rhinostat Kit is individually formulated for each patient depending upon their current decongestant nasal spray.  Physicians refer patients directly to the Rhinostat website at www.nasalspray.com.  Rhinostat collects all the information and dispatches the kit within one business day.

The cost of a Rhinostat Kit is $39.00.  Patients need only one kit and Rhinostat offers a 100% money back guarantee.  Rhinostat has been helping RM patients since 1999.  Since that time, tens of thousands of RM patients have been comfortably weaned from their decongestant sprays using this gradual withdrawal method.

Order Physician Sample